Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7398484 | 0.58 | — | — | |
| SCHEMBL126906 | 0.55 | FFAR3 (0.32) | — | |
| SCHEMBL10778290 | 0.55 | CYP3A4 (0.32) | — | |
| Hydrochloric Acid SCHEMBL8662463 | 0.53 | CYP3A4 (0.31) | — | |
| SCHEMBL3245915 | 0.53 | FFAR3 (0.35) | AKR1C1 | |
| 1-Aminocyclopropane Carboxylic Acid SCHEMBL61082 | 0.53 | — | — | |
| 1-Aminocyclopropane Carboxylic Acid SCHEMBL3967053 | 0.53 | — | — | |
| 1-Aminocyclopropane Carboxylic Acid SCHEMBL21462059 | 0.53 | NSD2 (0.63) | — | |
| SCHEMBL31348874 | 0.53 | NSD2 (0.63) | — | |
| 1-Aminocyclopropane Carboxylic Acid SCHEMBL1320265 | 0.51 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1581477-B1 | CYCLOALKENE DICARBOXYLIC ACID COMPOUNDS AS ANTI-INFLAMMATORY, IMMUNOMODULATORY AND ANTI-PROLIFERATORY AGENTS | 4SC AG (DE) | 2009-12-02 | — | — | EP | disclosed |
| CN-1939896-A | Cycloalkenedicarboxylic acid compounds as anti-inflammatory, immunomodulatory and antiproliferative agents | 4SC AG (DE) | 2007-04-04 | — | — | CN | disclosed |
| US-7071355-B2 | Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents | 4 SC AG (DE) | 2006-07-04 | — | — | US | disclosed |
| CN-1732147-A | Cycloalkenedicarboxylic acid compounds as anti-inflammatory, immunomodulatory and antiproliferative agents | 4 SC AG (DE) | 2006-02-08 | — | — | CN | disclosed |
| EP-1581477-A1 | CYCLOALKENE DICARBOXYLIC ACID COMPOUNDS AS ANTI-INFLAMMATORY, IMMUNOMODULATORY AND ANTI-PROLIFERATORY AGENTS | 4SC AG (DE) | 2005-10-05 | — | — | EP | disclosed |
| US-20040176458-A1 | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents | 4 SC AG (DE) | 2004-09-09 | — | — | US | disclosed |
| WO-2004056746-A1 | CYCLOALKENE DICARBOXYLIC ACID COMPOUNDS AS ANTI-INFLAMMATORY, IMMUNOMODULATORY AND ANTI-PROLIFERATORY AGENTS | 4SC AG (DE) | 2004-07-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040176458-A1 | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents | MSR1, PPARG, PPARA | NPSR1 295/4885AKR1C1 1441/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.